MLKL and neoplasm: Importantly, these alterations were abolished when tumors were subcutaneously implanted in the immune-competent mice (Fig. 2f, g), which echoed the tumor growth phenotypes and suggested that the enhanced anti-tumor immune response in the liver may account for the impeded tumor growth upon MLKL depletion.